CAS: 1095207-05-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Crenezumab REF: TM-T77152CAS: 1095207-05-8 | 95% - 95% | 275,00 €~2.493,00 € | Mar 07 Ene 25 |
 | Crenezumab REF: 3D-CLA1279CAS: 1095207-05-8 | - - - | A consultar | Mié 15 Ene 25 |
Crenezumab
CAS:1095207-05-8
Crenezumab (MABT 5102A) is a fully humanized anti-amyloid-beta antibody that binds to multiple forms of …
Pureza:
95% - 95%
Forma y color:
Liquid
Ref: TM-T77152
| 1mg | 275,00 € | ||
| 5mg | 812,00 € | ||
| 10mg | 1.287,00 € | ||
| 25mg | 1.850,00 € | ||
| 50mg | 2.493,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Crenezumab
CAS:1095207-05-8
A fully humanized monoclonal antibody (from mouse) against human 1-42 β-amyloid (Aβ).
Ref: 3D-CLA1279
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 15 de Enero de 2025
